Orthofix Medical Inc Is Being Sued For Violating Securities Regulations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by […]

The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against STMicroelectronics N.V.

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a category motion lawsuit against STMicroelectronics N.V. ("STMicroelectronics" or "the Company") (NYSE:STM) violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S.

Methode Electronics, Inc. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Methode Electronics, Inc. ("Methode" or "the Company") (NYSE:MEI) violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

ARC Document Solutions Inc May Have Defrauded The Public And The Schall Law Firm Urges Shareholders To Join An Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in ARC Document Solutions, Inc. ("ARC Document Solutions" or "the Company") (NYSE:ARC) for potential breaches of fiduciary duty on the part of its directors and

Verve Therapeutics Inc Is Being Sued For Securities Related Infractions And Shareholders With Losses Should Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verve Therapeutics, Inc. ("Verve" or "the Company") (NASDAQ:VERV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

The Schall Law Firm Seeks Investor Participation In A Lawsuit Against Starbucks Corporation For Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Starbucks Corporation ("Starbucks" or "the Company") (NASDAQ:SBUX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

The Schall Law Firm Is Inquiring Into Dollar General Corporation For Possible Securities Fraud And Affected Shareholders Should Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dollar General Corporation ("Dollar General" or "the Company") (NYSE:DG) for violations of the securities laws. The investigation focuses on whether the Company issued false

Super Micro Computer Inc Is Being Sued For Possible Securities Fraud And Shareholders Are Encouraged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Super Micro Computer, Inc. ("Super Micro" or "the Company") (NASDAQ:SMCI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

The Schall Law Firm Is Looking Into Enfusion, Inc. For Possible Securities Fraud And Affected Stockholders Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading

CrowdStrike Holdings, Inc. May Have Violated Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CrowdStrike Holdings, Inc. ("CrowdStrike" or "the Company") (NASDAQ:CRWD) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

Scroll to Top